JCVI recommends that mRNA vaccines like the Pfizer and Moderna jabs are the most effective for the UK’s booster programme
There are no plans to order further supplies of the Oxford/AstraZeneca Covid vaccine for the UK, it has been revealed, as experts expressed hope a new jab designed to target two variants will form the backbone of the autumn booster programme.
Deemed a British success story, and estimated to have saved millions of lives worldwide, the Oxford/AstraZeneca Covid jab played a key role early in the UK’s vaccination programme. But Prof Anthony Harnden, deputy chair of the Joint Committee on Vaccination and Immunisation (JCVI), has suggested the jab is unlikely to be used in the future.
Read the original article at The Guardian